Ares Capital Corp ARCC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ARCC is a good fit for your portfolio.
News
-
Thinking about buying stock in Adial Pharmaceuticals, Ares Capital Corp, SilverSun Technologies, Neuroone Medical Technologies, or enGene Holdings?
-
Business development companies should withstand 2024 economic slowdown, but credit conditions will weaken, Fitch says
-
Ares Capital Corporation Appoints Scott Lem as Chief Financial Officer
-
BetterInvesting™ Magazine Update on Gentex Corp. and Ares Capital Corp.
-
Ares Capital Corporation Announces September 30, 2023 Financial Results and Declares Fourth Quarter 2023 Dividend of $0.48 Per Share
-
Ares Capital Corporation Schedules Earnings Release for the Third Quarter Ended September 30, 2023
-
Ares debuts second SPAC IPO in uncertain times but raises less capital than the first
-
Private equity firm Compass widens reach into healthcare as a bright spot in moribund M&A market
Trading Information
- Previous Close Price
- $19.79
- Day Range
- $19.71–19.86
- 52-Week Range
- $16.96–20.17
- Bid/Ask
- $19.72 / $19.73
- Market Cap
- $11.23 Bil
- Volume/Avg
- 2.3 Mil / 2.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 8.45
- Price/Sales
- 4.33
- Dividend Yield
- 9.71%
- Dividend Yield (Forward)
- 9.71%
- Total Yield
- 9.71%
Company Profile
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in U.S. middle-market companies with investment opportunities as well as in larger companies. Its portfolio comprises of first lien senior secured loans, second lien senior secured loans, and mezzanine debt (subordinated unsecured loan), which may include equity components that are diversified by industry and sector. The company may invest in preferred and common equity investments to a lesser proportion. Its revenue mainly consists of interest and dividend income received from the investment made.
- Sector
- Financial Services
- Industry
- Asset Management
- Stock Style Box
- Mid Value
- Total Number of Employees
- —
- Website
- https://www.arescapitalcorp.com
Competitors
Valuation
|
Metric
|
ARCC
|
|---|---|
Price/Earnings (Normalized) | 8.45 |
Price/Book Value | 1.04 |
Price/Sales | 4.33 |
Price/Cash Flow | 19.26 |
Price/Earnings
ARCC
Financial Strength
|
Metric
|
ARCC
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
ARCC
|
|---|---|
Return on Assets (Normalized) | 5.76% |
Return on Equity (Normalized) | 12.78% |
Return on Invested Capital (Normalized) | — |
Return on Assets
ARCC
Asset Management Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
BLK
| BlackRock Inc | Sxvkt | $112.2 Bil | |
BX
| Blackstone Inc | Lscdsm | $86.4 Bil | |
KKR
| KKR & Co Inc Ordinary Shares | Xyrkcpr | $66.8 Bil | |
BK
| Bank of New York Mellon Corp | Svx | $37.2 Bil | |
AMP
| Ameriprise Financial Inc | Zppxqv | $35.7 Bil | |
STT
| State Street Corporation | Vkcnp | $22.6 Bil | |
TROW
| T. Rowe Price Group Inc | Xfv | $22.5 Bil | |
NTRS
| Northern Trust Corp | Chst | $16.7 Bil | |
CG
| The Carlyle Group Inc | Twsfmgg | $12.8 Bil | |
BEN
| Franklin Resources Inc | Cxkvys | $12.5 Bil |